[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Standard Biotools Inc (LAB)

Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 302,145
  • Shares Outstanding, K 390,368
  • Annual Sales, $ 85,330 K
  • Annual Income, $ -74,900 K
  • EBIT $ -90 M
  • EBITDA $ -81 M
  • 60-Month Beta 1.39
  • Price/Sales 3.80
  • Price/Cash Flow N/A
  • Price/Book 0.58
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings $-0.02 on 05/05/26
  • Next Earnings Date 08/10/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Options Overview Details

View History
  • Implied Volatility 285.60% (+67.94%)
  • Historical Volatility 124.14%
  • IV Percentile 63%
  • IV Rank 37.13%
  • IV High 735.30% on 03/16/26
  • IV Low 20.04% on 09/04/25
  • Expected Move (DTE 23) 0.0000 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 83
  • Volume Avg (30-Day) 186
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 3,069
  • Open Int (30-Day) 4,542
  • Expected Range 0.7921 to 0.7921

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.05
  • Growth Rate Est. (year over year) +1,998,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7619 +3.96%
on 06/22/26
1.2900 -38.60%
on 06/04/26
-0.2379 (-23.10%)
since 05/22/26
3-Month
0.7619 +3.96%
on 06/22/26
1.2900 -38.60%
on 06/04/26
-0.1817 (-18.66%)
since 03/23/26
52-Week
0.7619 +3.96%
on 06/22/26
1.7200 -53.95%
on 12/22/25
-0.4379 (-35.60%)
since 06/23/25

Most Recent Stories

More News
Are ROKU, PAYO, LAB, FOX Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

ROKU : 135.05 (-0.11%)
PAYO : 7.06 (+0.57%)
FOXA : 48.79 (-1.21%)
LAB : 0.7921 (+2.34%)
FOX : 44.55 (-0.85%)
LAB Stock Alert: Halper Sadeh LLC is Investigating Whether Standard BioTools Inc. is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that...

LAB : 0.7921 (+2.34%)
Standard BioTools and Treeline Biosciences Announce Merger Agreement

Combined company to operate as Treeline Biosciences, advancing a deep pipeline of small molecule inhibitors, protein degraders and targeted therapy antibody-drug conjugates Company to be led by Treeline CEO and...

LAB : 0.7921 (+2.34%)
Standard BioTools: Q1 Earnings Snapshot

Standard BioTools: Q1 Earnings Snapshot

LAB : 0.7921 (+2.34%)
Standard BioTools Reports First Quarter 2026 Financial Results

BOSTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended March 31, 2026....

LAB : 0.7921 (+2.34%)
Can Standard BioTools Prove Cost Cuts Translate to Survival Without Revenue Momentum?

Barchart Research What to Expect from LAB Earnings LAB Generated May 4, 2026 Current Price $0.9350 EPS Estimate $$-0.04 Consensus Rating Moderate Buy Average Move 8.90% Can Standard BioTools Prove Cost...

LAB : 0.7921 (+2.34%)
Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026

BOSTON, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish its first quarter 2026 financial results on Tuesday, May 5, 2026, after U.S....

LAB : 0.7921 (+2.34%)
Standard BioTools: Q4 Earnings Snapshot

Standard BioTools: Q4 Earnings Snapshot

LAB : 0.7921 (+2.34%)
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results

BOSTON, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter and fiscal year...

LAB : 0.7921 (+2.34%)
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

BOSTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish fourth quarter and full year 2025 financial results on Tuesday, February 24,...

LAB : 0.7921 (+2.34%)

Business Summary

Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm...

See More

Key Turning Points

3rd Resistance Point 0.8736
2nd Resistance Point 0.8504
1st Resistance Point 0.8213
Last Price 0.7921
1st Support Level 0.7690
2nd Support Level 0.7458
3rd Support Level 0.7167

See More

52-Week High 1.7200
Fibonacci 61.8% 1.3540
Fibonacci 50% 1.2409
Fibonacci 38.2% 1.1279
Last Price 0.7921
52-Week Low 0.7619

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.